1 |
MARTINEZ F D, VERCELLI D. Asthma[J]. Lancet, 2013, 382(9901): 1360-1372.
|
2 |
NETWORK. G A. The Global Asthma Report 2018[R/OL]. Auckland, Global Asthma Network, 2018, .
|
3 |
LUO W, HU J, XU W, et al. Distinct spatial and temporal roles for Th1, Th2, and Th17 cells in asthma[J]. Front Immunol, 2022, 13: 974066.
|
4 |
BADOLATI I, SVERREMARK-EKSTROM E, VAN DER HEIDEN M. Th9 cells in allergic diseases: A role for the microbiota?[J]. Scand J Immunol, 2020, 91(4): e12857.
|
5 |
CHEN W, CAO Y, ZHONG Y, et al. The Mechanisms of Effector Th Cell Responses Contribute to Treg Cell Function: New Insights into Pathogenesis and Therapy of Asthma[J]. Front Immunol, 2022, 13: 862866.
|
6 |
TAMASAUSKIENE L, SITKAUSKIENE B. Role of Th22 and IL-22 in pathogenesis of allergic airway diseases: Pro-inflammatory or anti-inflammatory effect?[J]. Pediatr Neonatol, 2018, 59(4): 339-344.
|
7 |
YAO Y, WANG Z C, YU D, et al. Role of allergen-specific T-follicular helper cells in immunotherapy[J]. Curr Opin Allergy Clin Immunol, 2018, 18(6): 495-501.
|
8 |
EL-MEZAYEN R E, MATSUMOTO T. In vitro responsiveness to IL-18 in combination with IL-12 or IL-2 by PBMC from patients with bronchial asthma and atopic dermatitis[J]. Clin Immunol, 2004, 111(1): 61-68.
|
9 |
YASUDA K, NAKANISHI K, TSUTSUI H. Interleukin-18 in Health and Disease[J]. Int J Mol Sci, 2019, 20(3):649.
|
10 |
SAWADA M, KAWAYAMA T, IMAOKA H, et al. IL-18 induces airway hyperresponsiveness and pulmonary inflammation via CD4+ T cell and IL-13[J]. PLoS One, 2013, 8(1): e54623.
|
11 |
ISHIKAWA Y, YOSHIMOTO T, NAKANISHI K. Contribution of IL-18-induced innate T cell activation to airway inflammation with mucus hypersecretion and airway hyperresponsiveness[J]. Int Immunol, 2006, 18(6): 847-855.
|
12 |
KURODA-MORIMOTO M, TANAKA H, HAYASHI N, et al. Contribution of IL-18 to eosinophilic airway inflammation induced by immunization and challenge with Staphylococcus aureus proteins[J]. Int Immunol, 2010, 22(7): 561-570.
|
13 |
CHARRAD R, BERRAIES A, HAMDI B, et al. Anti-inflammatory activity of IL-37 in asthmatic children: Correlation with inflammatory cytokines TNF-alpha, IL-beta, IL-6 and IL-17A[J]. Immunobiology, 2016, 221(2): 182-187.
|
14 |
FENG K N, MENG P, ZHANG M, et al. IL-24 Contributes to Neutrophilic Asthma in an IL-17A-Dependent Manner and Is Suppressed by IL-37[J]. Allergy Asthma Immunol Res, 2022, 14(5): 505-527.
|
15 |
HUANG N, LIU K, LIU J, et al. Interleukin-37 alleviates airway inflammation and remodeling in asthma via inhibiting the activation of NF-kappaB and STAT3 signalings[J]. Int Immunopharmacol, 2018, 55: 198-204.
|
16 |
LV J, XIONG Y, LI W, et al. IL-37 inhibits IL-4/IL-13-induced CCL11 production and lung eosinophilia in murine allergic asthma[J]. Allergy, 2018, 73(8): 1642-1652.
|
17 |
CHEN L X, XU C M, GAO F, et al. Associations of IL-18 and IL-9 expressions and gene polymorphisms with asthma[J]. Eur Rev Med Pharmacol Sci, 2020, 24(12): 6931-6938.
|
18 |
ODA H, KAWAYAMA T, IMAOKA H, et al. Interleukin-18 expression, CD8(+) T cells, and eosinophils in lungs of nonsmokers with fatal asthma[J]. Ann Allergy Asthma Immunol, 2014, 112(1): 23-28 e21.
|
19 |
KIM B G, LEE P H, LEE S H, et al. Effect of TiO(2) Nanoparticles on Inflammasome-Mediated Airway Inflammation and Responsiveness[J]. Allergy Asthma Immunol Res, 2017, 9(3): 257-264.
|
20 |
YAMAGATA S, TOMITA K, SATO R, et al. Interleukin-18-deficient mice exhibit diminished chronic inflammation and airway remodelling in ovalbumin-induced asthma model[J]. Clin Exp Immunol, 2008, 154(3): 295-304.
|
21 |
ZHANG H, ZHANG Z, XU Y. Effects of interleukin-18 on asthmatic airway inflammation and nuclear factor kappa-B in murine models[J]. Chin Med J (Engl), 2003, 116(3): 323-327.
|
22 |
MUKHERJEE M, BULIR D C, RADFORD K, et al. Sputum autoantibodies in patients with severe eosinophilic asthma[J]. J Allergy Clin Immunol, 2018, 141(4): 1269-1279.
|
23 |
WU H, ROMIEU I, SHI M, et al. Evaluation of candidate genes in a genome-wide association study of childhood asthma in Mexicans[J]. J Allergy Clin Immunol, 2010, 125(2): 321-327 e313.
|
24 |
JAIN A, SONG R, WAKELAND E K, et al. T cell-intrinsic IL-1R signaling licenses effector cytokine production by memory CD4 T cells[J]. Nat Commun, 2018, 9(1): 3185.
|
25 |
SMELTZ R B, CHEN J, HU-LI J, et al. Regulation of interleukin (IL)-18 receptor alpha chain expression on CD4(+) T cells during T helper (Th)1/Th2 differentiation. Critical downregulatory role of IL-4[J]. J Exp Med, 2001, 194(2): 143-153.
|
26 |
AITA T, YAMAMURA M, KAWASHIMA M, et al. Expression of interleukin 12 receptor (IL-12R) and IL-18R on CD4+ T cells from patients with rheumatoid arthritis[J]. J Rheumatol, 2004, 31(3): 448-456.
|
27 |
LUNDING L, WEBERING S, VOCK C, et al. IL-37 requires IL-18Ralpha and SIGIRR/IL-1R8 to diminish allergic airway inflammation in mice[J]. Allergy, 2015, 70(4): 366-373.
|
28 |
BERRAIES A, HAMDI B, AMMAR J, et al. Increased expression of thymic stromal lymphopoietin in induced sputum from asthmatic children[J]. Immunol Lett, 2016, 178: 85-91.
|
29 |
CAVALLI G, DINARELLO C A. Suppression of inflammation and acquired immunity by IL-37[J]. Immunol Rev, 2018, 281(1): 179-190.
|
30 |
ZHU J, DONG J, JI L, et al. Anti-Allergic Inflammatory Activity of Interleukin-37 Is Mediated by Novel Signaling Cascades in Human Eosinophils[J]. Front Immunol, 2018, 9: 1445.
|
31 |
MENG P, CHEN Z G, ZHANG T T, et al. IL-37 alleviates house dust mite-induced chronic allergic asthma by targeting TSLP through the NF-kappaB and ERK1/2 signaling pathways[J]. Immunol Cell Biol, 2019, 97(4): 403-415.
|